To visit the global (BRAND) website, please choose from the options below:
This website is intended to provide informationto an international audience outsie the USA, the UK,
Austria ans Southern African coutries including South Africa. If you are a US visitor, please click here .
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.
Adverse events should also be reported to Bayer plc.
Tel: 0118 206 3500 | Fax: 0118 206 3703 | Email: pvuk@bayer.com
Please report any quality complaint to Bayer Plc.
Email: gb-quality-complaints@bayer.com
This website is intended for UK Healthcare Professionals.
© Bayer. This website is produced by Bayer.
Side effects should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store.
You should also discuss any side effects you are experiencing with your doctor.
By reporting side effects you can help provide more information on the safety of this medicine.
Please report any quality complaint to Bayer Plc.
To visit the global (BRAND) website, please choose from the options below:
Side effects should be reported. Reporting forms and information can be found at yellowcard.mhra.co.uk or search for MHRA Yellow Card in Google Play or Apple App Store.
You should also discuss any side effects you are experiencing with your doctor.
By reporting side effects you can help provide more information on the safety of this medicine.
Please report any quality complaint to Bayer Plc.
February 2021, PP-PF-ONC-GB-0139